Can Molecular Imaging Measure T-cell Activation?

Cancer Research
Peter L Choyke

Abstract

Successful immunotherapy usually depends on activation of T cells in the tumor microenvironment. However, ascertaining whether T-cell activation has occurred in vivo is difficult without invasive tissue sampling. Inducible T-cell costimulator (ICOS) is a specific marker of T-cell activation that can be imaged by radiolabeling an anti-ICOS antibody and performing PET scanning. Hopefully, this agent will be the first of many molecular imaging constructs that can determine whether T-cell activation has occurred and could be used in drug development and clinical trials of cancer immunotherapy.See related article by Xiao et al., p. 3023.

References

Jul 24, 2003·Nature Reviews. Immunology·Christopher E Rudd, Helga Schneider
Sep 28, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John S YiKent J Weinhold
Mar 30, 2018·The Journal of Clinical Investigation·Israt S AlamSanjiv S Gambhir
May 26, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Aaron T Mayer, Sanjiv S Gambhir
Oct 12, 2018·Cancer Treatment Reviews·Elly L van der VeenElisabeth G E de Vries
Nov 21, 2018·Radiology·Mizuki NishinoF Stephen Hodi
Oct 6, 2019·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Neeta Pandit-TaskarJedd D Wolchok
Mar 12, 2020·Cancer Research·Zunyu XiaoSanjiv S Gambhir

❮ Previous
Next ❯

Citations

Apr 1, 2021·Proceedings of the National Academy of Sciences of the United States of America·Yang ZhaoZhaofei Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.